Please enable JavaScript to continue using this application.

Compare $CAMP vs $GLSI | Chartloom

Compare

$CAMP vs $GLSI

CAMP4 Therapeutics Corp · Greenwich Lifesciences Inc

CAMP

CAMP4 Therapeutics Corp

GLSI

Greenwich Lifesciences Inc

Compare $CAMP vs $GLSI

Comparing CAMP4 Therapeutics Corp and Greenwich Lifesciences Inc

CAMPCAMP4 Therapeutics Corp

GLSIGreenwich Lifesciences Inc

CAMPCAMP4 Therapeutics Corp

Market cap

$196M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.59x

Rev growth (TTM)

40.3%

YTD performance

-37.2%

52W performance

6.5%

FCF yield

-14.7%

GLSIGreenwich Lifesciences Inc

Market cap

$243M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-15.1%

52W performance

44.4%

FCF yield

-5.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAMP

GLSI

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

GLSI

Greenwich Lifesciences Inc

Market Cap

CAMP$196M

GLSI$243M

Enterprise Value

CAMP$109M

GLSI$234M

Price

CAMP$3.77

GLSI$16.53

P/E Ratio

CAMPN/A

GLSIN/A

P/S Ratio

CAMP46.44x

GLSI0.00x

EV/Sales

CAMP25.94x

GLSI0.00x

EV/EBITDA

CAMP0.00x

GLSI0.00x

P/B Ratio

CAMP8.12x

GLSI79.96x

P/FCF Ratio

CAMPN/A

GLSIN/A

EV/FCF

CAMP-3.81x

GLSI-18.72x

PEG Ratio

CAMPN/A

GLSIN/A

Forward P/E (NTM)

CAMPN/A

GLSIN/A

Forward P/S (NTM)

CAMP19.59x

GLSIN/A

Revenue (TTM)

CAMP$4M

GLSI$0

Revenue Growth (YoY)

CAMP40.3%

GLSIN/A

Forward Rev Growth

CAMP-10.8%

GLSI0.0%

Gross Margin (TTM)

CAMP35.8%

GLSI0.0%

Operating Margin (TTM)

CAMP0.0%

GLSI0.0%

EBITDA Margin (TTM)

CAMP-1199.3%

GLSI0.0%

Net Margin (TTM)

CAMP-2543.7%

GLSI0.0%

FCF Margin (TTM)

CAMP-681.2%

GLSIN/A

Net Income (TTM)

CAMP$-107M

GLSI$-22M

FCF (TTM)

CAMP$-29M

GLSI$-12M

EPS (TTM)

CAMP-$1.85

GLSI-$1.48

ROE (TTM)

CAMP-19474.0%

GLSI-79376.0%

ROA (TTM)

CAMP-10642.0%

GLSI-29531.0%

ROIC (TTM)

CAMP-19457.0%

GLSI-79376.0%

Cash

CAMP$86M

GLSI$9M

Debt

CAMP$0

GLSI$0

Net Cash/Debt

CAMP$86M

GLSI$9M

Current Ratio (TTM)

CAMP4.70x

GLSI1.54x

Quick Ratio (TTM)

CAMP4.69x

GLSI1.54x

Debt/Equity (TTM)

CAMP0.00x

GLSI0.00x

Debt/Assets (TTM)

CAMP0.0%

GLSI0.0%

Interest Coverage (TTM)

CAMPN/A

GLSIN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

GLSI0.00x

Beta

CAMP-24.51

GLSI1.54

52W Performance

CAMP6.5%

GLSI44.4%

YTD Performance

CAMP-37.2%

GLSI-15.1%

% from 52W High

CAMP-51.4%

GLSI-51.5%

% from 52W Low

CAMP31.8%

GLSI112.5%

Asset Turnover (TTM)

CAMP0.79x

GLSI0.00x

FCF Yield (TTM)

CAMP-14.7%

GLSI-5.1%

Earnings Yield (TTM)

CAMP-54.8%

GLSI-8.9%

Dividend Yield (TTM)

CAMPN/A

GLSIN/A

Rule of 40

CAMP-640.9

GLSI0.0

EV/GP/RG

CAMP0.53

GLSIN/A

Ticker research

View CAMP research View GLSI research

Metric	CAMP CAMP4 Therapeutics Corp	GLSI Greenwich Lifesciences Inc
Market & Valuation
Market Cap	$196M	$243M
Enterprise Value	$109M	$234M
Price	$3.77	$16.53
P/E Ratio	N/A	N/A
P/S Ratio	46.44x	0.00x
EV/Sales	25.94x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.12x	79.96x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.81x	-18.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	40.3%	N/A
Forward Rev Growth	-10.8%	0.0%
Profitability
Gross Margin (TTM)	35.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1199.3%	0.0%
Net Margin (TTM)	-2543.7%	0.0%
FCF Margin (TTM)	-681.2%	N/A
Net Income (TTM)	$-107M	$-22M
FCF (TTM)	$-29M	$-12M
EPS (TTM)	-$1.85	-$1.48
ROE (TTM)	-19474.0%	-79376.0%
ROA (TTM)	-10642.0%	-29531.0%
ROIC (TTM)	-19457.0%	-79376.0%
Financial Health
Cash	$86M	$9M
Debt	$0	$0
Net Cash/Debt	$86M	$9M
Current Ratio (TTM)	4.70x	1.54x
Quick Ratio (TTM)	4.69x	1.54x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	1.54
52W Performance	6.5%	44.4%
YTD Performance	-37.2%	-15.1%
% from 52W High	-51.4%	-51.5%
% from 52W Low	31.8%	112.5%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.00x
FCF Yield (TTM)	-14.7%	-5.1%
Earnings Yield (TTM)	-54.8%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	0.0
EV/GP/RG	0.53	N/A
Ticker research	View CAMP research	View GLSI research

Valuation

P/S Ratio

GLSI

0.00x

CAMP

46.44x

EV/FCF

GLSI

-18.72x

CAMP

-3.81x

Growth & revenue

Revenue Growth TTM

CAMP

40.3%

Forward Revenue Growth

GLSI

0.0%

CAMP

-10.8%

Profitability & performance

Gross Margin

CAMP

35.8%

GLSI

0.0%

ROE

CAMP

-19474.0%

GLSI

-79376.0%

FCF Yield %

GLSI

-5.1%

CAMP

-14.7%

52-Week Performance

GLSI

44.4%

CAMP

6.5%

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

GLSI

Greenwich Lifesciences Inc

Market Cap

CAMP$196M

GLSI$243M

Enterprise Value

CAMP$109M

GLSI$234M

Price

CAMP$3.77

GLSI$16.53

P/E Ratio

CAMPN/A

GLSIN/A

P/S Ratio

CAMP46.44x

GLSI0.00x

EV/Sales

CAMP25.94x

GLSI0.00x

EV/EBITDA

CAMP0.00x

GLSI0.00x

P/B Ratio

CAMP8.12x

GLSI79.96x

P/FCF Ratio

CAMPN/A

GLSIN/A

EV/FCF

CAMP-3.81x

GLSI-18.72x

PEG Ratio

CAMPN/A

GLSIN/A

Forward P/E (NTM)

CAMPN/A

GLSIN/A

Forward P/S (NTM)

CAMP19.59x

GLSIN/A

Revenue (TTM)

CAMP$4M

GLSI$0

Revenue Growth (YoY)

CAMP40.3%

GLSIN/A

Forward Rev Growth

CAMP-10.8%

GLSI0.0%

Gross Margin (TTM)

CAMP35.8%

GLSI0.0%

Operating Margin (TTM)

CAMP0.0%

GLSI0.0%

EBITDA Margin (TTM)

CAMP-1199.3%

GLSI0.0%

Net Margin (TTM)

CAMP-2543.7%

GLSI0.0%

FCF Margin (TTM)

CAMP-681.2%

GLSIN/A

Net Income (TTM)

CAMP$-107M

GLSI$-22M

FCF (TTM)

CAMP$-29M

GLSI$-12M

EPS (TTM)

CAMP-$1.85

GLSI-$1.48

ROE (TTM)

CAMP-19474.0%

GLSI-79376.0%

ROA (TTM)

CAMP-10642.0%

GLSI-29531.0%

ROIC (TTM)

CAMP-19457.0%

GLSI-79376.0%

Cash

CAMP$86M

GLSI$9M

Debt

CAMP$0

GLSI$0

Net Cash/Debt

CAMP$86M

GLSI$9M

Current Ratio (TTM)

CAMP4.70x

GLSI1.54x

Quick Ratio (TTM)

CAMP4.69x

GLSI1.54x

Debt/Equity (TTM)

CAMP0.00x

GLSI0.00x

Debt/Assets (TTM)

CAMP0.0%

GLSI0.0%

Interest Coverage (TTM)

CAMPN/A

GLSIN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

GLSI0.00x

Beta

CAMP-24.51

GLSI1.54

52W Performance

CAMP6.5%

GLSI44.4%

YTD Performance

CAMP-37.2%

GLSI-15.1%

% from 52W High

CAMP-51.4%

GLSI-51.5%

% from 52W Low

CAMP31.8%

GLSI112.5%

Asset Turnover (TTM)

CAMP0.79x

GLSI0.00x

FCF Yield (TTM)

CAMP-14.7%

GLSI-5.1%

Earnings Yield (TTM)

CAMP-54.8%

GLSI-8.9%

Dividend Yield (TTM)

CAMPN/A

GLSIN/A

Rule of 40

CAMP-640.9

GLSI0.0

EV/GP/RG

CAMP0.53

GLSIN/A

Ticker research

View CAMP research View GLSI research

Metric	CAMP CAMP4 Therapeutics Corp	GLSI Greenwich Lifesciences Inc
Market & Valuation
Market Cap	$196M	$243M
Enterprise Value	$109M	$234M
Price	$3.77	$16.53
P/E Ratio	N/A	N/A
P/S Ratio	46.44x	0.00x
EV/Sales	25.94x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.12x	79.96x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.81x	-18.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	40.3%	N/A
Forward Rev Growth	-10.8%	0.0%
Profitability
Gross Margin (TTM)	35.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1199.3%	0.0%
Net Margin (TTM)	-2543.7%	0.0%
FCF Margin (TTM)	-681.2%	N/A
Net Income (TTM)	$-107M	$-22M
FCF (TTM)	$-29M	$-12M
EPS (TTM)	-$1.85	-$1.48
ROE (TTM)	-19474.0%	-79376.0%
ROA (TTM)	-10642.0%	-29531.0%
ROIC (TTM)	-19457.0%	-79376.0%
Financial Health
Cash	$86M	$9M
Debt	$0	$0
Net Cash/Debt	$86M	$9M
Current Ratio (TTM)	4.70x	1.54x
Quick Ratio (TTM)	4.69x	1.54x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	1.54
52W Performance	6.5%	44.4%
YTD Performance	-37.2%	-15.1%
% from 52W High	-51.4%	-51.5%
% from 52W Low	31.8%	112.5%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.00x
FCF Yield (TTM)	-14.7%	-5.1%
Earnings Yield (TTM)	-54.8%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	0.0
EV/GP/RG	0.53	N/A
Ticker research	View CAMP research	View GLSI research